IP Library › Assignment 049857/0551
Patent Assignment
Reel/Frame 049857/0551

Assignment of Assignor's Interest

Recorded: 2019-07-25 Pages: 4
Assignors
QIAN, WENYUAN
Executed: 2019-07-22
YANG, CHUNDAO
Executed: 2019-07-22
LI, ZHENGWEI
Executed: 2019-07-22
LI, JIE
Executed: 2019-07-22
LI, JIAN
Executed: 2019-07-24
CHEN, SHUHUI
Executed: 2019-07-24
Assignee
SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT CO., LTD.
FLOOR 3, INNOVATION BUILDING, CHANGJIANG ROAD NO. 315, NEW AND HI-TECH DISTRICT, SHIJIAZHUANG, HEBEI, 050035, CHINA
Covered Property (1)
1,2-Dihydro-3H-Pyrazolo[3,4-D]Pyrimidin-3-One Derivative as WEE1 Inhibitor
Application: 16/479,936 →
Publication: US 2020/0017528
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 7, 2022
From: SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT CO., LTD.
To: WUXI BIOCITY BIOPHARMACEUTICS CO., LTD.
Reel/Frame 060122/0719 →